The platform was built and validated specifically for dogs, and LatusPet plans to add further conditions each year, with work underway to extend it to other species...
First and only melanoma gene expression profiling test that is both designated as an FDA Breakthrough Device and included in the NCCN guidelines for T1b and T2a cutaneous melanoma patients...
CERAS in Peru, Memorial Hospital in Turkey, CENALFES in Bolivia, Seoul IVF in South Korea, and Procrearte in Argentina...
As both a practising doctor, and a successful medtech founder, there are three main factors that drive uptake that need to be met for acceptance and adoption...
ALZpath Strengthens Market Leadership with Abbott Agreement to Help Enable Early Alzheimer’s Diagnosis at Global Scale ...
The award will support validation of a non-invasive fetal EEG system designed to detect brain distress during delivery....
The company is exploring innovative approaches to accelerate healing, improve clinical decision-making, and expand treatment options for patients with chronic wounds...
The SERRA-I early feasibility study is evaluating the A-FLUX Reducer System for symptomatic coronary microvascular dysfunction....
The UAE launch follows Overture's recent market entries in Brazil and India...
The platform turns genomic, biomarker and patient data into adaptive clinical intelligence for licensed healthcare practitioners....
